M. Luster

Markus Luster

After qualifying from medical school in (1985-1992), from the University of Essen, Prof. Luster undertook training in paediatric haematology/oncology at the University of Madison, Wisconsin, USA. From there, he pursued a 6-year fellowship in the Department of Nuclear Medicine at the University of W├╝rzburg, where, in November 2000, he became a consultant. In 2008 Prof. Luster moved to the University of Ulm to become professor of nuclear medicine and in June 2013 became full professor and chairman of the Department of Nuclear Medicine at the University of Marburg.
Prof. Luster has been involved in multiple clinical trials in endocrinology and paediatric oncology, including several multicentric, international trials in differentiated thyroid carcinoma.
In addition, he is a member of numerous medical societies, including the German Society of Nuclear Medicine, the European Organization for Research and Treatment of Cancer (EORTC) Endocrine Tumor Study Group, and the European Association of Nuclear Medicine. From 2008 to 2012 he was chairman of the therapy committee for the European Association of Nuclear Medicine and a member of the scientific advisory board of the National Patient Support group for Thyroid Cancer. Since October 2014 he is chairing the newly founded Thyroid Committee of the EANM.